Guizuo Wang

803 total citations
48 papers, 598 citations indexed

About

Guizuo Wang is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Guizuo Wang has authored 48 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Guizuo Wang's work include Pulmonary Hypertension Research and Treatments (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Asthma and respiratory diseases (6 papers). Guizuo Wang is often cited by papers focused on Pulmonary Hypertension Research and Treatments (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Asthma and respiratory diseases (6 papers). Guizuo Wang collaborates with scholars based in China, Russia and United States. Guizuo Wang's co-authors include Dong Han, Manxiang Li, Wenli Shang, Dong Han, Xinming Xie, Shaojun Li, Dexin Zhang, Jiamei Lu, Yanting Zhu and Rui Ke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Guizuo Wang

44 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guizuo Wang China 17 216 190 117 80 74 48 598
Mahendra Damarla United States 22 471 2.2× 342 1.8× 155 1.3× 110 1.4× 177 2.4× 46 1.0k
Xiuhong Yang China 14 113 0.5× 172 0.9× 71 0.6× 62 0.8× 35 0.5× 45 620
Wang Deng China 19 281 1.3× 353 1.9× 82 0.7× 152 1.9× 207 2.8× 47 886
Linjing Gong China 12 96 0.4× 288 1.5× 84 0.7× 134 1.7× 49 0.7× 27 562
Sohel Zaedi Japan 17 111 0.5× 183 1.0× 159 1.4× 134 1.7× 92 1.2× 41 680
Zhigang Chang China 16 78 0.4× 365 1.9× 42 0.4× 90 1.1× 107 1.4× 37 752
Mauo-Ying Bien Taiwan 16 271 1.3× 149 0.8× 75 0.6× 67 0.8× 102 1.4× 26 710
Hongmei Yao China 15 141 0.7× 295 1.6× 107 0.9× 57 0.7× 133 1.8× 41 898
Aastha Mishra India 12 81 0.4× 108 0.6× 59 0.5× 25 0.3× 29 0.4× 30 483
John S. Harrington United States 9 87 0.4× 287 1.5× 77 0.7× 134 1.7× 75 1.0× 13 569

Countries citing papers authored by Guizuo Wang

Since Specialization
Citations

This map shows the geographic impact of Guizuo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guizuo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guizuo Wang more than expected).

Fields of papers citing papers by Guizuo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guizuo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guizuo Wang. The network helps show where Guizuo Wang may publish in the future.

Co-authorship network of co-authors of Guizuo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guizuo Wang. A scholar is included among the top collaborators of Guizuo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guizuo Wang. Guizuo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shang, Wenli, Guizuo Wang, & Dong Han. (2025). Benefits of Nanocurcumin on Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Integrative and Complementary Medicine. 32(1). 40–46.
2.
3.
Wang, Guizuo, et al.. (2024). Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stem Cell Reviews and Reports. 20(4). 931–937. 3 indexed citations
4.
Wang, Guizuo, et al.. (2023). Statins in hospitalized COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials. Journal of Medical Virology. 95(6). e28823–e28823. 15 indexed citations
5.
Shang, Wenli, Yingying Zhang, Guizuo Wang, & Dong Han. (2023). Anakinra was not associated with lower mortality in hospitalised COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials. Reviews in Medical Virology. 33(2). e2418–e2418. 9 indexed citations
6.
7.
Zhao, Yali, Xiangli Zhang, Guizuo Wang, et al.. (2023). LXA4 inhibits TGF-β1-induced airway smooth muscle cells proliferation and migration by suppressing the Smad/YAP pathway. International Immunopharmacology. 118. 110144–110144. 6 indexed citations
8.
Shang, Wenli, Yan Wang, Guizuo Wang, & Dong Han. (2022). Benefits of ozone on mortality in patients with COVID-19: A systematic review and meta-analysis. Complementary Therapies in Medicine. 72. 102907–102907. 9 indexed citations
9.
Shang, Wenli, Yingying Zhang, Lu Liu, et al.. (2022). Benefits of continuous positive airway pressure on blood pressure in patients with hypertension and obstructive sleep apnea: a meta-analysis. Hypertension Research. 45(11). 1802–1813. 22 indexed citations
10.
Wang, Guizuo, et al.. (2021). Association between early bronchiolitis and the development of childhood asthma: a meta-analysis. BMJ Open. 11(5). e043956–e043956. 20 indexed citations
11.
Zhang, Wei, Yadan Wang, Weijie Li, & Guizuo Wang. (2021). The Association Between the Baseline and the Change in Neutrophil-to-Lymphocyte Ratio and Short-Term Mortality in Patients With Acute Respiratory Distress Syndrome. Frontiers in Medicine. 8. 636869–636869. 17 indexed citations
12.
Wang, Guizuo, et al.. (2019). Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis. European Journal of Internal Medicine. 70. 39–42. 5 indexed citations
13.
Xia, Meng, Yonghong Zhang, Yanqin Liu, et al.. (2018). PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model. Inflammation. 41(6). 2079–2089. 14 indexed citations
14.
Liu, Yun, et al.. (2015). Expression, purification and identification of Pla a1 in a codon-optimized Platanus pollen allergen. Molecular Medicine Reports. 12(2). 2197–2202. 4 indexed citations
15.
Zhang, Yonghong, Shaojun Li, Guizuo Wang, et al.. (2014). Changes of HMGB1 and sRAGE during the recovery of COPD exacerbation.. PubMed Central. 17 indexed citations
16.
Xie, Xinming, Yonghong Zhang, Rui Ke, et al.. (2014). Vitamin D-binding protein gene polymorphisms and chronic obstructive pulmonary disease susceptibility: A meta-analysis. Biomedical Reports. 3(2). 183–188. 8 indexed citations
17.
Wang, Guizuo, Dong Han, Yonghong Zhang, et al.. (2013). A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS.. Europe PMC (PubMed Central). 25 indexed citations
18.
Wang, Guizuo. (2012). Improved regionalized flow duration curve based runoff simulation of ungauged basin. Water Resources and Hydropower Engineering.
19.
Li, Manxiang, Yuan Liu, Yonghong Zhang, et al.. (2012). Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(10). 961–968. 18 indexed citations
20.
Ren, Liliang, et al.. (2009). Application of spatially varying storage capacity model for runoff parameterization in semi-arid catchment. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahendra Damarla Breakdown of academic impact, for papers by Xiuhong Yang Breakdown of academic impact, for papers by Wang Deng Breakdown of academic impact, for papers by Linjing Gong Breakdown of academic impact, for papers by Sohel Zaedi Breakdown of academic impact, for papers by Zhigang Chang Breakdown of academic impact, for papers by Mauo-Ying Bien Breakdown of academic impact, for papers by Hongmei Yao Breakdown of academic impact, for papers by Aastha Mishra Breakdown of academic impact, for papers by John S. Harrington
Rankless by CCL
2026